Georgia Medical Cannabis Rollout: Fine Fettle opened its Evans dispensary June 26, just as Georgia’s expanded medical cannabis program took effect July 1, with new eligible conditions including Lupus, HIV, and Inflammatory Bowel Disease. CBD/THC Policy Pressure: Louisiana THC seltzers and edibles face a potential federal ban push tied to a Sept. 30 deadline, with industry lobbying aimed at stopping limits on THC per container. Medical Hemp Product Pipeline: MIRA Pharmaceuticals reported positive preclinical formulation results for SKNY-1, highlighting favorable oral bioavailability and brain penetration with once-daily dosing potential for obesity and addiction-related disorders. Cannabinoid Licensing Deal: Argent BioPharma advanced a global licensing framework for CannEpil with Splash Beverage Group, including US$5.5M upfront consideration and a royalty structure tied to global revenue. Prison Contraband Risk: A UK prisons watchdog warned drone “menus” now let inmates order cannabis and other “lifestyle drugs,” raising new enforcement and safety concerns. Regulated Market Entry (Mexico): A Mexico legal boutique outlined planning issues for companies entering regulated sectors, including cannabis/hemp and life sciences, covering product classification, claims, distribution, and contract compliance. Mental Health & Cannabis Use: A study reported cannabidiol shows no significant benefit for treating psychotic disorders, adding to the mixed clinical picture around CBD.